Examination Report |
1 | Additional Representation Sheet | 02 Dec 2014 |
1 | TM-1 | 02 Dec 2014 |
10 | TM-R(RENEWAL OF TRADE MARK) | 10 Oct 2024 |
2 | Additional Representation Sheet | 02 Dec 2014 |
2 | TM-1 | 02 Dec 2014 |
3 | Reply to Exam Report (MIS-R) | 31 Jan 2017 |
4 | Reply to Exam Report (MIS-R) | 31 Jan 2017 |
5 | TM-M(EXTENSION OF TIME) | 25 Apr 2018 |
6 | TM-M(EXTENSION OF TIME) | 12 Jul 2018 |
7 | Affidavit | 21 Aug 2018 |
8 | Journal Copy | 20 Oct 2018 |
9 | Certificate | 17 Jan 2019 |
1 | Dispatching of Examination Report for : 2854381 | 3767845 | 1865736 | 18 Jul 2016 |
2 | Hearing Notice (Show Cause) | 6080518 | 2753925 | 19 Mar 2018 |
3 | Hearing Notice (Adjourned) | 6443093 | 2971469 | 30 May 2018 |
4 | Hearing Notice (Adjourned) | 6668184 | 3098762 | 16 Jul 2018 |
5 | Tribunal Accepted Notice for : 2854381 | 6856652 | 3232793 | 21 Aug 2018 |
6 | O3 NOTICE | 18871354 | 6914329 | 19 Sep 2024 |
7 | RENEWAL INTIMATION LETTER | 18989239 | 13 Oct 2024 |
Relidomide was applied on 02 December 2014.
Trademark application was filed by RELIANCE LIFE SCIENCES.
Trademark application has been filed under following classes.
5
As per IP India, trademark application is on the following stage:
Registered.
Listed application Id of Relidomide is 2854381.
Relidomide is a DEVICE as per IP India data.